Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.22.2.2
Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2022
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following as of September 30, 2022 and December 31, 2021 (in thousands):

 

 

September 30, 2022

 

 

December 31, 2021

 

External research and preclinical development

 

$

11,450

 

 

$

8,274

 

Employee compensation and benefits

 

 

6,747

 

 

 

6,344

 

Professional fees

 

 

3,377

 

 

 

953

 

Facilities and other

 

 

139

 

 

 

53

 

Accrued expenses

 

$

21,713

 

 

$

15,624